231 related articles for article (PubMed ID: 26466573)
1. Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection.
Zhou YM; Zhang XF; Li B; Sui CJ; Yang JM
BMC Cancer; 2015 Oct; 15():689. PubMed ID: 26466573
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinoma.
Amisaki M; Saito H; Tokuyasu N; Sakamoto T; Honjo S; Fujiwara Y
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):323-329. PubMed ID: 29631957
[TBL] [Abstract][Full Text] [Related]
3. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
4. Recurrent hepatocellular carcinoma and poorer overall survival in patients undergoing left-sided compared with right-sided partial hepatectomy.
Valenzuela A; Ha NB; Gallo A; Bonham C; Ahmed A; Melcher M; Kim LH; Esquivel C; Concepcion W; Ayoub WS; Lutchman GA; Daugherty T; Nguyen MH
J Clin Gastroenterol; 2015 Feb; 49(2):158-64. PubMed ID: 24804988
[TBL] [Abstract][Full Text] [Related]
5. Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?
Khandoga A; Drefs M; Schoenberg M; Schiergens T; Frenes K; Op den Winkel M; Trumm C; Angele MK; Guba M; Werner J; Rentsch M
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1045-1053. PubMed ID: 28562395
[TBL] [Abstract][Full Text] [Related]
6. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
7. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma.
Hirokawa F; Hayashi M; Asakuma M; Shimizu T; Inoue Y; Uchiyama K
Surg Oncol; 2016 Mar; 25(1):24-9. PubMed ID: 26979637
[TBL] [Abstract][Full Text] [Related]
9. Higher complication rate in hepatocellular carcinoma patients undergoing prophylactic cholecystectomy with curative hepatic resection.
Kaibori M; Kubo S; Nagano H; Hayashi M; Nakai T; Ishizaki M; Matsui K; Uenishi T; Takemuraz S; Wada H; Marubashi S; Komeda K; Hirokawa F; Nakata Y; Uchiyama K; Kwon M
Hepatogastroenterology; 2014 Oct; 61(135):2028-34. PubMed ID: 25713906
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
11. Predictors of poor prognosis by recurrence patterns after curative hepatectomy for hepatocellular carcinoma in Child-Pugh classification A.
Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
Hepatogastroenterology; 2015; 62(137):164-8. PubMed ID: 25911889
[TBL] [Abstract][Full Text] [Related]
12. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
Zhang ZY; Zhou ZQ; Zhou GW
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747
[TBL] [Abstract][Full Text] [Related]
13. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.
Choi KK; Kim SH; Choi SB; Lim JH; Choi GH; Choi JS; Kim KS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1646-51. PubMed ID: 21592228
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study.
Regimbeau JM; Abdalla EK; Vauthey JN; Lauwers GY; Durand F; Nagorney DM; Ikai I; Yamaoka Y; Belghiti J
J Surg Oncol; 2004 Jan; 85(1):36-41. PubMed ID: 14696085
[TBL] [Abstract][Full Text] [Related]
15. Second and third hepatectomies for recurrent hepatocellular carcinoma are justified.
Wu CC; Cheng SB; Yeh DC; Wang J; P'eng FK
Br J Surg; 2009 Sep; 96(9):1049-57. PubMed ID: 19672929
[TBL] [Abstract][Full Text] [Related]
16. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
[TBL] [Abstract][Full Text] [Related]
17. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194
[TBL] [Abstract][Full Text] [Related]
18. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
[TBL] [Abstract][Full Text] [Related]
19. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
Takada Y; Otsuka M; Todoroki T; Fukao K
Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
[TBL] [Abstract][Full Text] [Related]
20. Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma.
Uemura M; Sasaki Y; Yamada T; Gotoh K; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
Ann Surg Oncol; 2014 May; 21(5):1719-25. PubMed ID: 24464342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
